Effects of MPEP on expression of food-, MDMA- or amphetamine-conditioned place preference in rats

被引:56
作者
Herzig, V
Capuani, EMI
Kovar, KA
Schmidt, WJ
机构
[1] Univ Tubingen, Fac Biol, Inst Zool, D-72076 Tubingen, Germany
[2] Univ Tubingen, Grad Sch Neural & Behav Sci, Int Max Planck Res Sch, D-72076 Tubingen, Germany
[3] Univ Tubingen, Dept Pharmaceut Analyt Chem, Inst Pharmaceut, D-72076 Tubingen, Germany
关键词
D O I
10.1080/13556210500223272
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have revealed the effectiveness of 2-methyl-6-(phenylethynyl) pyridine ( MPEP), a highly selective antagonist of metabotropic glutamate receptors subtype 5 (mGluR5), in conditioned drug reward. In a previous study we showed that MPEP blocks expression of context-conditioned morphine- but not cocaine reward in the rat. The present study now examines the effectiveness of MPEP in the expression of context-conditioned food, MDMA ('ecstasy') or amphetamine reward. Therefore, three groups of rats were conditioned either to food, MDMA or amphetamine in the conditioned place preference (CPP) paradigm. After conditioning, CPP expression and locomotion were determined simultaneously in the presence and absence of the respective reward (i.e. food or drug), or after application of 50 mg/kg MPEP ( the dose that was most effective in reducing morphine CPP expression in our previous study). As a result, MPEP reduced locomotion in all groups. Furthermore, only expression of amphetamine CPP was inhibited by MPEP, while expression of food and MDMA CPP was not affected, suggesting that the MPEP-induced inhibition of amphetamine CPP expression was not causally linked to the reduction of locomotion. Overall, we conclude that MPEP reduces expression of context-conditioned amphetamine but not MDMA or food reward.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 28 条
[1]   [3H]methoxymethyl-3-[(2-methylyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain:: In vitro and in vivo characterization [J].
Anderson, JJ ;
Rao, SP ;
Rowe, B ;
Giracello, DR ;
Holtz, G ;
Chapman, DF ;
Tehrani, L ;
Bradbury, MJ ;
Cosford, NDP ;
Varney, MA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :1044-1051
[2]   mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior [J].
Bäckström, P ;
Bachteler, D ;
Koch, S ;
Hyytiä, P ;
Spanagel, R .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) :921-928
[3]   EFFECTS OF DOPAMINERGIC AND GLUTAMATERGIC RECEPTOR ANTAGONISTS ON THE ACQUISITION AND EXPRESSION OF COCAINE CONDITIONING PLACE PREFERENCE [J].
CERVO, L ;
SAMANIN, R .
BRAIN RESEARCH, 1995, 673 (02) :242-250
[4]   Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice [J].
Chiamulera, C ;
Epping-Jordan, MP ;
Zocchi, A ;
Marcon, C ;
Cottiny, C ;
Tacconi, S ;
Corsi, M ;
Orzi, F ;
Conquet, F .
NATURE NEUROSCIENCE, 2001, 4 (09) :873-874
[5]   Limbic activation during cue-induced cocaine craving [J].
Childress, AR ;
Mozley, PD ;
McElgin, W ;
Fitzgerald, J ;
Reivich, M ;
O'Brien, CP .
AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (01) :11-18
[6]   3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: A potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity [J].
Cosford, NDP ;
Tehrani, L ;
Roppe, J ;
Schweiger, E ;
Smith, ND ;
Anderson, J ;
Bristow, L ;
Brodkin, J ;
Jiang, XH ;
McDonald, I ;
Rao, S ;
Washburn, M ;
Varney, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) :204-206
[7]   Extinction of ethanol-induced conditioned place preference and conditioned place aversion: effects of naloxone [J].
Cunningham, CL ;
Henderson, CM ;
Bormann, NM .
PSYCHOPHARMACOLOGY, 1998, 139 (1-2) :62-70
[8]   Behavioural differentiation of rats confronted to a complex diving-for-food situation [J].
Grasmuck, V ;
Desor, D .
BEHAVIOURAL PROCESSES, 2002, 58 (1-2) :67-77
[9]   Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo [J].
Heidbreder, CA ;
Bianchi, H ;
Lacroix, LP ;
Faedo, S ;
Perdona, E ;
Remelli, R ;
Cavanni, P ;
Crespi, F .
SYNAPSE, 2003, 50 (04) :269-276
[10]   Anti-craving drugs acamprosate and naloxone do not reduce expression of morphine conditioned place preference in isolated and group-housed rats [J].
Herzig, V ;
Schmidt, WJ .
NEUROSCIENCE LETTERS, 2005, 374 (02) :119-123